SIRT3 and Parkinson disease: In several chemical drug trials, it has been found that SIRT3 agonists such as theacrine (Duan et al. 2020) and trans-(-)-ε-viniferin (ε-viniferin) (Zhang et al. 2020a, b, c, d) can inhibit the occurrence and development of PD.